Multicomponent (bio)markers for obesity risk prediction: a scoping review protocol
Author:
Vahid FarhadORCID, Dessenne CoralieORCID, Tur Josep AORCID, Bouzas CristinaORCID, Devaux YvanORCID, Malisoux LaurentORCID, Monserrat-Mesquida MargalidaORCID, Sureda AntoniORCID, Desai Mahesh SORCID, Turner Jonathan DORCID, Lamy ElsaORCID, Perez-Jimenez MariaORCID, Ravn-Haren GitteORCID, Andersen RikkeORCID, Forberger SarahORCID, Nagrani RajiniORCID, Ouzzahra Yacine, Fontefrancesco Michele FilippoORCID, Onorati Maria GiovannaORCID, Bonetti Gino Gabriel, de-Magistris TizianaORCID, Bohn TorstenORCID
Abstract
IntroductionDespite international efforts, the number of individuals struggling with obesity is still increasing. An important aspect of obesity prevention relates to identifying individuals at risk at early stage, allowing for timely risk stratification and initiation of countermeasures. However, obesity is complex and multifactorial by nature, and one isolated (bio)marker is unlikely to enable an optimal risk stratification and prognosis for the individual; rather, a combined set is required. Such a multicomponent interpretation would integrate biomarkers from various domains, such as classical markers (eg, anthropometrics, blood lipids), multiomics (eg, genetics, proteomics, metabolomics), lifestyle and behavioural attributes (eg, diet, physical activity, sleep patterns), psychological traits (mental health status such as depression) and additional host factors (eg, gut microbiota diversity), also by means of advanced interpretation tools such as machine learning. In this paper, we will present a protocol that will be employed for a scoping review that attempts to summarise and map the state-of-the-art in the area of multicomponent (bio)markers related to obesity, focusing on the usability and effectiveness of such biomarkers.Methods and analysisPubMed, Scopus, CINAHL and Embase databases will be searched using predefined key terms to identify peer-reviewed articles published in English until January 2024. Once downloaded into EndNote for deduplication, CADIMA will be employed to review and select abstracts and full-text articles in a two-step procedure, by two independent reviewers. Data extraction will then be carried out by several independent reviewers. Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews and Peer Review of Electronic Search Strategies guidelines will be followed. Combinations employing at least two biomarkers from different domains will be mapped and discussed.Ethics and disseminationEthical approval is not required; data will rely on published articles. Findings will be published open access in an international peer-reviewed journal. This review will allow guiding future directions for research and public health strategies on obesity prevention, paving the way towards multicomponent interventions.
Funder
Ministry of Higher Education and Research, Luxembourg COVIRNA EU COST ACTIONS Fonds National de la Recherche Luxembourg HORIZON EUROPE Research and Innovation Heart Foundation Daniel Wagner Luxembourg Instituto de Salud Carlos III, Spain, CIBEROBN COST Association Horizon Europe Research and Innovation Programme
Reference40 articles.
1. Haththotuwa R , Wijeyaratne C , Senarath U . Obesity and obstetrics. The Netherlands: Elsevier Amsterdam, 2020. 2. World Health Organization . WHO European regional obesity report 2022: World Health Organization. Regional Office for Europe; 2022. 3. Anthropometric and adiposity indicators and risk of type 2 diabetes: systematic review and dose-response meta-analysis of cohort studies;Jayedi;BMJ,2022 4. Bohn T , Samouda H , Aa A . Chapter 7 - dietary patterns and type 2 diabetes—relationship to metabolic syndrome and inflammation. In: Hébert JR , Hofseth LJ , eds. Diet, inflammation, and health. Academic Press, 2022: 261–366. 5. Vahid F , Chiriboga D , Bohn T , et al . Chapter 8 - diet, inflammation, and cardiovascular disease. In: Hébert JR , Hofseth LJ , eds. Diet, inflammation, and health. Academic Press, 2022: 367–472.
|
|